Young, Wendy B.

Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis

Di Paolo, J. A., Huang, T., Balazs, M., Barbosa, J., Barck, K. H., Bravo, B. J., Carano, R. A. D., Darrow, J., Davies, D. R., DeForge, L. E., et al. (2011) · Nature Chemical Biology

Rheumatoid Arthritis Research and TherapiesNatural Compounds in Disease Treatment

Cited by 340

Battling Btk mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations

Johnson, A. R., Kohli, P. B., Katewa, A., Gogol, E., Belmont, L. D., Choy, R., Penuel, E., Burton, L., Eigenbrot, C., Yu, C., et al. (2016) · ACS Chemical Biology

Chronic Lymphocytic Leukemia ResearchProtein Degradation and Inhibitors

Cited by 137

Human T Cells Armed with Her2/neu Bispecific Antibodies Divide, Are Cytotoxic, and Secrete Cytokines with Repeated Stimulation

Grabert, R. C., Cousens, L. P., Smith, J. A., Olson, S., Gall, J., Young, W. B., Davol, P. A., & Lum, L. G. (2006) · Clinical Cancer Research

Immunotherapy and Immune ResponsesMonoclonal and Polyclonal Antibodies Research

Cited by 79